Piceatannol inhibits prototypic tumor promoter-induced cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression by blocking the activation of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) [84]. The gene discussed is PTGS2; the disease is neoplasm.